International Flavors & Fragrances Inc
- 取引所
- 米国株
- 国 / 地域
- USA
- 上場日
- 1981年12月31日
- 従業員数
- 21,500
- 公式サイト
- www.iff.com
総合バリュエーションレンジ · 保守的 $28–$35 / 妥当 $45–$60 / 楽観的 $65–$80。$76.4 時点で 楽観的な本源的価値レンジ内 · 多くの期待を織り込み済み。
レポート公開時 $78.03（2026年5月29日）
データ提供：EODHD、報告通貨で表示。参考情報であり、投資助言ではありません。
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, and complementary adjacent products in the United States, and internationally. It operates in through Taste, Food Ingredients, Health & Biosciences, and Scent segments. The Taste segment offers savory products such as soups, sauces, meat, fish, poultry, snacks; beverages consists of juice drinks, carbonated or flavored beverages, spirits; sweets comprising, bakery products, candy, cereal, chewing gum; and dairy products, such as yogurt, ice cream, cheese, and other products, as well as spices and seasoning ingredients for meat, food service, convenience, alternative protein and culinary products. The Food Ingredients segment provides natural, artificial, and plant-based specialty food ingredients; natural antioxidants and anti-microbials used for natural food preservation and shelf-life extension for beverages, cosmetic and healthcare products, pet food and feed additives; and savory solutions, such as spices, marinades, and mixtures, and inclusion products comprising combining flavorings with fruit, vegetables and other natural ingredients, as well as soy and pea protein with value-added formulations, emulsifiers and sweeteners. The Health & Biosciences segment offers enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications, as well as engages in health, food biosciences, home and personal care, animal nutrition and grain processing businesses. The Scent segment creates fragrance compounds, and fragrance ingredients. International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.
沿革
International Flavors & Fragrances Inc. (IFF) was incorporated in 1909 and is headquartered in New York, New York, with its IPO dated December 31, 1981. The company has grown into a diversified ingredients platform that embeds flavor, fragrance, biosciences and food ingredients into customer formulations rather than a single flavors-and-fragrances business. As of 2025 its continuing operations were restructured into four core segments: Taste, Food Ingredients, Health & Biosciences, and Scent. In 2024 J. Erik Fyrwald joined the board and became CEO, and the quarterly dividend was cut from $0.81 to $0.40 as the new team prioritized deleveraging, portfolio reshaping, and a later return of capital. In 2025 IFF completed the divestiture of its Pharma Solutions business, reducing net debt to credit-adjusted EBITDA below 3.0x (2.59x by year-end 2025), and initiated a strategic-alternatives review of its Food Ingredients segment; the board then authorized a $500 million buyback, with about 481,000 shares repurchased for roughly $35 million in the first quarter of 2026. The company carries the legacy of heavy acquisition activity, reflected in successive large goodwill impairments of $2.250 billion (2022), $2.623 billion (2023), $0.064 billion (2024), and $1.153 billion (2025). IFF employs about 21,500 people.
業界での地位
IFF operates in the specialty chemicals space as a multi-segment ingredients platform (Taste, Food Ingredients, Health & Biosciences, Scent) serving food, beverage, home and personal care, fragrance and health customers on a B2B basis. The traditional flavors-and-fragrances market was about €46.8 billion in 2025 with more than 500 active companies, where the top four players—Givaudan, IFF's relevant business, dsm-firmenich and Symrise—together held roughly 52% share, indicating a concentrated but not monopolistic industry. The competitors IFF lists in its annual report include Givaudan, Novonesis, DSM-Firmenich, Symrise, Kerry and ADM. Its customer base spans large global consumer-products companies and smaller customers; as last clearly disclosed in 2023, about 46% of sales came from global consumer-products companies and about 54% from small and medium customers, the top 25 customers accounted for about 32% of sales, and no single customer exceeded 10% of sales. IFF's competitive position rests on long-term customer relationships, application-development capability, regulatory expertise and a global manufacturing and supply network, with switching costs arising from formula reformulation, sensory validation, and stability and regulatory testing. On profitability it ranked behind the strongest peer: Givaudan's 2025 EBITDA margin was about 25.7%, while IFF's 2025 adjusted operating EBITDA of $2.086 billion implied an adjusted EBITDA margin of about 19.2%; 2025 segment sales were about $2.481 billion (Taste), $3.278 billion (Food Ingredients), $2.283 billion (Health & Biosciences) and $2.479 billion (Scent), with Food Ingredients consistently carrying lower margins than the other segments.
この銘柄のレポートはお使いの言語でまだありません。